Alpha fetoprotein (AFP) response and efficacy outcomes in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Kelley, R. K.; Rimassa, L.; Ryoo, B. Y.; Park, J. W.; Blanc, J. F.; Chan, S. L.; Dadduzio, V.; Yau, T. C.; Sen, S.; Markby, D. W.; Kaldate, R.; El-Khoueiry, A. B.; Cheng, A. L.; Meyer, T.; Abou-Alfa, G. K. |
| Abstract Title: | Alpha fetoprotein (AFP) response and efficacy outcomes in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 2019 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Jan 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000489107600452 |
| DOI: | 10.1200/JCO.2019.37.4_suppl.423 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 423 -- Source: Wos |
